Oncology Analytics, Inc., commonly referred to as Oncology Analytics, is a leading provider of advanced analytics and technology solutions in the oncology sector. Headquartered in the United States, the company operates across major regions, delivering innovative services to healthcare providers and payers. Founded in 2014, Oncology Analytics has achieved significant milestones, including the development of proprietary tools that enhance clinical decision-making and improve patient outcomes. The company’s core offerings include data-driven insights, treatment optimisation, and cost management solutions tailored specifically for oncology. What sets Oncology Analytics apart is its commitment to integrating clinical expertise with cutting-edge technology, ensuring that healthcare professionals have access to the most relevant information. With a strong market position, Oncology Analytics continues to be recognised for its contributions to improving cancer care and driving efficiencies within the healthcare system.
How does Oncology Analytics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Oncology Analytics, Inc.'s score of 60 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Oncology Analytics, Inc. reported total carbon emissions of approximately 571,871,000 kg CO2e. This figure includes Scope 1 emissions of about 28,064,000 kg CO2e, Scope 2 emissions of approximately 25,452,000 kg CO2e, and significant Scope 3 emissions amounting to around 518,354,000 kg CO2e. Comparatively, in 2023, the company’s total emissions were about 579,605,000 kg CO2e, with Scope 1 at approximately 28,215,000 kg CO2e, Scope 2 at around 25,308,000 kg CO2e, and Scope 3 emissions reaching about 526,081,000 kg CO2e. Oncology Analytics has set ambitious climate commitments, aiming to reduce operational greenhouse gas emissions (Scope 1 and 2) by 42% and Scope 3 emissions by 25% by 2030, using 2022 as a baseline. Furthermore, the company has established a long-term goal to achieve net zero emissions across all scopes by 2050. These initiatives reflect a proactive approach to addressing climate change and reducing their carbon footprint in the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | 2024 | |
---|---|---|---|
Scope 1 | 118,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 171,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 6,800,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Oncology Analytics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.